Central and peripheral cardiovascular actions of adrenomedullin 5, a novel member of the calcitonin gene-related peptide family, in mammals

Y. Takei, H. Hashimoto, K. Inoue, T. Osaki, K. Yoshizawa-Kumagaye, M. Tsunemi, T. X. Watanabe, Maho Ogoshi, N. Minamino, Y. Ueta

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Adrenomedullin 5 (AM5) is a new member of the calcitonin gene-related peptide (CGRP) family idetitified in teleost fish. Although its presence was suggested in the genome database of mammals, molecular identity and biological function of AM5 have not been examined yet. In this study, we cloned a cDNA encoding AM5 in the pig and examined its cardiovascular and renal effects. Putative mature AM5 was localized in the middle of prohormone and had potential signals for intermolecular ring formation and C-terminal amidation. The AM5 gene was expressed most abundantly in the spleen and thymus. Several AM5 genes were newly identified in the database of mammals, which revealed that the AM5 gene exists in primates, carnivores, and undulates but could not be identified in rodents. In primates, nucleotide deletion occurred in the mature AM5 sequence in anthropoids (human and chimp) during transition from the rhesus monkey. Synthetic mature AM5 injected intravenously into rats induced dose-dependent decreases in arterial pressure at 0.1-1 nmol/kg without apparent changes in heart rate. The decrease was maximal in 1 min and AM5 was approximately half as potent as AM. AM5 did not cause significant changes in urine flow and urine Na+ concentration at any dose. In contrast to the peripheral vasodepressor action, AM5 injected into the cerebral ventricle dose-dependently increased arterial pressure and heart rate at 0.1-1 nmol. The increase reached maximum more quickly after AM5 (5 min) than AM (15-20 min). AM5 added to the culture cells expressing calcitonin receptor-like receptor (CLR) or calcitonin receptor (CTR) together with one of the receptor activity-modifying proteins (RAMPs), the combination of which forms major receptors for the CGRP family, did not induce appreciable increases in cAMP production in any combination, although AM increased it at 1010 -10-9 M when added to the CLR and RAMP2/3 combination. These data indicate that AM5 seems to act on as yet unknown receptor(s) for AM5, other than CLP/CTR+RAMP, to exert central and peripheral cardiovascular actions in mammals.

Original languageEnglish
Pages (from-to)391-400
Number of pages10
JournalJournal of Endocrinology
Volume197
Issue number2
DOIs
Publication statusPublished - May 2008
Externally publishedYes

Fingerprint

Adrenomedullin
Calcitonin Gene-Related Peptide
Mammals
Receptor Activity-Modifying Proteins
Calcitonin Receptor-Like Protein
Calcitonin Receptors
Primates
Arterial Pressure
Adrenomedullin Receptors
Heart Rate
Chemical Databases
Urine
Calcitonin Gene-Related Peptide Receptors
Genes
Cerebral Ventricles
Macaca mulatta

ASJC Scopus subject areas

  • Endocrinology

Cite this

Central and peripheral cardiovascular actions of adrenomedullin 5, a novel member of the calcitonin gene-related peptide family, in mammals. / Takei, Y.; Hashimoto, H.; Inoue, K.; Osaki, T.; Yoshizawa-Kumagaye, K.; Tsunemi, M.; Watanabe, T. X.; Ogoshi, Maho; Minamino, N.; Ueta, Y.

In: Journal of Endocrinology, Vol. 197, No. 2, 05.2008, p. 391-400.

Research output: Contribution to journalArticle

Takei, Y, Hashimoto, H, Inoue, K, Osaki, T, Yoshizawa-Kumagaye, K, Tsunemi, M, Watanabe, TX, Ogoshi, M, Minamino, N & Ueta, Y 2008, 'Central and peripheral cardiovascular actions of adrenomedullin 5, a novel member of the calcitonin gene-related peptide family, in mammals', Journal of Endocrinology, vol. 197, no. 2, pp. 391-400. https://doi.org/10.1677/JOE-07-0541
Takei, Y. ; Hashimoto, H. ; Inoue, K. ; Osaki, T. ; Yoshizawa-Kumagaye, K. ; Tsunemi, M. ; Watanabe, T. X. ; Ogoshi, Maho ; Minamino, N. ; Ueta, Y. / Central and peripheral cardiovascular actions of adrenomedullin 5, a novel member of the calcitonin gene-related peptide family, in mammals. In: Journal of Endocrinology. 2008 ; Vol. 197, No. 2. pp. 391-400.
@article{fb54db854cd74280b6277f568a5fdfd3,
title = "Central and peripheral cardiovascular actions of adrenomedullin 5, a novel member of the calcitonin gene-related peptide family, in mammals",
abstract = "Adrenomedullin 5 (AM5) is a new member of the calcitonin gene-related peptide (CGRP) family idetitified in teleost fish. Although its presence was suggested in the genome database of mammals, molecular identity and biological function of AM5 have not been examined yet. In this study, we cloned a cDNA encoding AM5 in the pig and examined its cardiovascular and renal effects. Putative mature AM5 was localized in the middle of prohormone and had potential signals for intermolecular ring formation and C-terminal amidation. The AM5 gene was expressed most abundantly in the spleen and thymus. Several AM5 genes were newly identified in the database of mammals, which revealed that the AM5 gene exists in primates, carnivores, and undulates but could not be identified in rodents. In primates, nucleotide deletion occurred in the mature AM5 sequence in anthropoids (human and chimp) during transition from the rhesus monkey. Synthetic mature AM5 injected intravenously into rats induced dose-dependent decreases in arterial pressure at 0.1-1 nmol/kg without apparent changes in heart rate. The decrease was maximal in 1 min and AM5 was approximately half as potent as AM. AM5 did not cause significant changes in urine flow and urine Na+ concentration at any dose. In contrast to the peripheral vasodepressor action, AM5 injected into the cerebral ventricle dose-dependently increased arterial pressure and heart rate at 0.1-1 nmol. The increase reached maximum more quickly after AM5 (5 min) than AM (15-20 min). AM5 added to the culture cells expressing calcitonin receptor-like receptor (CLR) or calcitonin receptor (CTR) together with one of the receptor activity-modifying proteins (RAMPs), the combination of which forms major receptors for the CGRP family, did not induce appreciable increases in cAMP production in any combination, although AM increased it at 1010 -10-9 M when added to the CLR and RAMP2/3 combination. These data indicate that AM5 seems to act on as yet unknown receptor(s) for AM5, other than CLP/CTR+RAMP, to exert central and peripheral cardiovascular actions in mammals.",
author = "Y. Takei and H. Hashimoto and K. Inoue and T. Osaki and K. Yoshizawa-Kumagaye and M. Tsunemi and Watanabe, {T. X.} and Maho Ogoshi and N. Minamino and Y. Ueta",
year = "2008",
month = "5",
doi = "10.1677/JOE-07-0541",
language = "English",
volume = "197",
pages = "391--400",
journal = "Journal of Endocrinology",
issn = "0022-0795",
publisher = "Society for Endocrinology",
number = "2",

}

TY - JOUR

T1 - Central and peripheral cardiovascular actions of adrenomedullin 5, a novel member of the calcitonin gene-related peptide family, in mammals

AU - Takei, Y.

AU - Hashimoto, H.

AU - Inoue, K.

AU - Osaki, T.

AU - Yoshizawa-Kumagaye, K.

AU - Tsunemi, M.

AU - Watanabe, T. X.

AU - Ogoshi, Maho

AU - Minamino, N.

AU - Ueta, Y.

PY - 2008/5

Y1 - 2008/5

N2 - Adrenomedullin 5 (AM5) is a new member of the calcitonin gene-related peptide (CGRP) family idetitified in teleost fish. Although its presence was suggested in the genome database of mammals, molecular identity and biological function of AM5 have not been examined yet. In this study, we cloned a cDNA encoding AM5 in the pig and examined its cardiovascular and renal effects. Putative mature AM5 was localized in the middle of prohormone and had potential signals for intermolecular ring formation and C-terminal amidation. The AM5 gene was expressed most abundantly in the spleen and thymus. Several AM5 genes were newly identified in the database of mammals, which revealed that the AM5 gene exists in primates, carnivores, and undulates but could not be identified in rodents. In primates, nucleotide deletion occurred in the mature AM5 sequence in anthropoids (human and chimp) during transition from the rhesus monkey. Synthetic mature AM5 injected intravenously into rats induced dose-dependent decreases in arterial pressure at 0.1-1 nmol/kg without apparent changes in heart rate. The decrease was maximal in 1 min and AM5 was approximately half as potent as AM. AM5 did not cause significant changes in urine flow and urine Na+ concentration at any dose. In contrast to the peripheral vasodepressor action, AM5 injected into the cerebral ventricle dose-dependently increased arterial pressure and heart rate at 0.1-1 nmol. The increase reached maximum more quickly after AM5 (5 min) than AM (15-20 min). AM5 added to the culture cells expressing calcitonin receptor-like receptor (CLR) or calcitonin receptor (CTR) together with one of the receptor activity-modifying proteins (RAMPs), the combination of which forms major receptors for the CGRP family, did not induce appreciable increases in cAMP production in any combination, although AM increased it at 1010 -10-9 M when added to the CLR and RAMP2/3 combination. These data indicate that AM5 seems to act on as yet unknown receptor(s) for AM5, other than CLP/CTR+RAMP, to exert central and peripheral cardiovascular actions in mammals.

AB - Adrenomedullin 5 (AM5) is a new member of the calcitonin gene-related peptide (CGRP) family idetitified in teleost fish. Although its presence was suggested in the genome database of mammals, molecular identity and biological function of AM5 have not been examined yet. In this study, we cloned a cDNA encoding AM5 in the pig and examined its cardiovascular and renal effects. Putative mature AM5 was localized in the middle of prohormone and had potential signals for intermolecular ring formation and C-terminal amidation. The AM5 gene was expressed most abundantly in the spleen and thymus. Several AM5 genes were newly identified in the database of mammals, which revealed that the AM5 gene exists in primates, carnivores, and undulates but could not be identified in rodents. In primates, nucleotide deletion occurred in the mature AM5 sequence in anthropoids (human and chimp) during transition from the rhesus monkey. Synthetic mature AM5 injected intravenously into rats induced dose-dependent decreases in arterial pressure at 0.1-1 nmol/kg without apparent changes in heart rate. The decrease was maximal in 1 min and AM5 was approximately half as potent as AM. AM5 did not cause significant changes in urine flow and urine Na+ concentration at any dose. In contrast to the peripheral vasodepressor action, AM5 injected into the cerebral ventricle dose-dependently increased arterial pressure and heart rate at 0.1-1 nmol. The increase reached maximum more quickly after AM5 (5 min) than AM (15-20 min). AM5 added to the culture cells expressing calcitonin receptor-like receptor (CLR) or calcitonin receptor (CTR) together with one of the receptor activity-modifying proteins (RAMPs), the combination of which forms major receptors for the CGRP family, did not induce appreciable increases in cAMP production in any combination, although AM increased it at 1010 -10-9 M when added to the CLR and RAMP2/3 combination. These data indicate that AM5 seems to act on as yet unknown receptor(s) for AM5, other than CLP/CTR+RAMP, to exert central and peripheral cardiovascular actions in mammals.

UR - http://www.scopus.com/inward/record.url?scp=43249114418&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=43249114418&partnerID=8YFLogxK

U2 - 10.1677/JOE-07-0541

DO - 10.1677/JOE-07-0541

M3 - Article

C2 - 18434369

AN - SCOPUS:43249114418

VL - 197

SP - 391

EP - 400

JO - Journal of Endocrinology

JF - Journal of Endocrinology

SN - 0022-0795

IS - 2

ER -